| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 06/30/2005 | WO2005033049A3 METHOD OF PREPARING 4-AMINO-1H-IMIDAZO(4,5-c)QUINOLINES AND ACID ADDITION SALTS THEREOF |
| 06/30/2005 | WO2005032484A3 Alkoxy substituted imidazoquinolines |
| 06/30/2005 | WO2004084809A3 Neuroprotective macrocylic compounds and methods for their use |
| 06/30/2005 | US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143413 imidazo[4,5-c]quinoline-4-amine compounds; can induce the biosynthesis of various cytokines; use treating viral diseases and neoplastic diseases |
| 06/30/2005 | US20050143401 Anticancer agents; (4-(3-Fluorobenzyloxy)-3-chlorophenyl)-(6-(2-((2-methanesulphonyl-ethylamino)ethyl)-thiazol-4-yl)-quinazolin-4-yl)-amine |
| 06/30/2005 | US20050143398 mitogen-activated protein (MAP), p38 kinase ( alpha and beta)-associated conditions; antiinflammatory and antidiabetic agent; inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease, asthma |
| 06/30/2005 | US20050143395 (2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-3-yl)-acetaldehyde, and, 3-{2-[4-(6-fluorobenzo[d]isoxazol-3-yl)-piperidin-1-yl]-vinyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one; intermediates to risperidone |
| 06/30/2005 | US20050143372 Compounds, pharmaceutical compositions and methods of use therefor |
| 06/30/2005 | US20050143371 Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors |
| 06/30/2005 | CA2557004A1 Pyrazolo [3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors |
| 06/30/2005 | CA2550074A1 Novel chelating agents and highly luminescent and stable chelates and their use |
| 06/30/2005 | CA2550012A1 Urea derivative, process for producing the same and use |
| 06/30/2005 | CA2549869A1 Pyrido- and pyrimidopyrimidine derivatives as anti- proliferative agents |
| 06/30/2005 | CA2549860A1 Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2549598A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2549144A1 Novel crystalline forms of 2, 3 dimethyl-8- (2, 6-dimethylbenzylamino) -n-hydroxyethyl-imidazo [1, 2-a] pyridine-6-carboxamide mesylate salt |
| 06/30/2005 | CA2549098A1 Hiv protease inhibiting compounds |
| 06/30/2005 | CA2549042A1 Tricyclic benzimidazoles |
| 06/30/2005 | CA2548781A1 Synthesis of a polymorph of 4-amino-5-chloro-2-methoxy-n-(1-azabicyclo[3.3.1]non-4-yl)benzamide hydrochloride hydrate |
| 06/30/2005 | CA2547633A1 Hydronopol derivatives as agonists on human orl1 receptors |
| 06/29/2005 | EP1547996A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 06/29/2005 | EP1547616A1 Preventive and/or therapeutic drugs for itch |
| 06/29/2005 | EP1546157A2 PHENYL-AZA-BENZIMIDAZOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION |
| 06/29/2005 | EP1546149A1 Modified pictet-spengler reaction and products prepared therefrom |
| 06/29/2005 | EP1546148A1 Therapeutic compounds based on pyrazolopyridine derivatives |
| 06/29/2005 | EP1546147A1 Morpholine-bridged indazole derivatives |
| 06/29/2005 | EP1546143A1 Heterocyclic substituted piperazines for the treatment of schizophrenia |
| 06/29/2005 | EP1546120A2 Pharmaceutical compositions for treatment of parkinson's disease |
| 06/29/2005 | EP1546112A2 Imidazolopyridines and methods of making and using the same |
| 06/29/2005 | EP1545532A2 Heterocyclic compounds |
| 06/29/2005 | EP1545515A1 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors |
| 06/29/2005 | EP1545502A2 Keto cannabinoids with therapeutic indications |
| 06/29/2005 | EP1481268A4 Nanofilm and membrane compositions |
| 06/29/2005 | EP1480635A4 Macrocyclic module compositions |
| 06/29/2005 | EP1373272B1 Tert. alkylphenoxy substituted polycyclic compounds |
| 06/29/2005 | EP1347759B1 Antibacterial compounds |
| 06/29/2005 | EP1343786B1 Novel pyridine-substituted pyrazolopyridine derivatives |
| 06/29/2005 | EP1315727B1 7-oxo pyridopyrimidines |
| 06/29/2005 | EP1274701B1 [1,4']-bipiperidine compounds |
| 06/29/2005 | EP1165077B1 Viral treatment |
| 06/29/2005 | CN1633435A Tricyclic n-acyl compounds |
| 06/29/2005 | CN1633434A Imidazo[1, 2-a]pyridine derivative |
| 06/29/2005 | CN1633433A N-aroyl cyclic amines |
| 06/29/2005 | CN1633414A Chemical compounds |
| 06/29/2005 | CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/29/2005 | CN1631887A Nitryl methylene derivatives and uses thereof |
| 06/29/2005 | CN1208336C Tert-butyl-(7-methyl-imidazo [1, 2-a] pyridine-3-yl)-amine derivatives |
| 06/29/2005 | CN1208323C Alpha-substituted carboxylic acid derivatives |
| 06/28/2005 | US6911543 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| 06/28/2005 | US6911542 Pyrazino[1′,2′:1,6]pyrido[3,4b]indole derivatives |
| 06/28/2005 | US6911469 For therapy of disease treatable based on a blood sugar level-depressing activity or a disease treatable based on a cGMP-PDE inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity |
| 06/28/2005 | US6911452 Central nervous system disorders, sleep disorders, eating disorders. sexual disorders, hypotensive agents |
| 06/28/2005 | CA2174106C Imidazo[1,5-a]quinolines for treatment of anxiety and sleep disorders |
| 06/23/2005 | WO2005056554A2 Azepinoindole derivatives as pharmaceutical agents |
| 06/23/2005 | WO2005056552A1 Naphthyridine derivatives and their use as modulators of muscarinic receptors |
| 06/23/2005 | WO2005056550A2 Heterocyclic anti-migraine agents |
| 06/23/2005 | WO2005056524A2 Therapeutic agents useful for treating pain |
| 06/23/2005 | WO2005056013A1 Dpp-iv inhibitors |
| 06/23/2005 | WO2005055951A2 Methods and compositions for slowing aging |
| 06/23/2005 | WO2005014584A9 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparation and use as modulators of apoptosis |
| 06/23/2005 | WO2004089307A8 Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists |
| 06/23/2005 | US20050137395 E.g., 6-[(7-iodoquinolin-4-yl)oxy]-N,2-dimethyl-1-benzofuran-3-carboxamide; antiproliferative agent for hyperproliferative disorders being either cancerous or noncancerous; vasculogenesis or angiogenesis inhibitors; adminstered with hypotensive agent, antitumor agents, mitotic inhibitors and others |
| 06/23/2005 | US20050137227 Crystalline form III of anhydrous moxifloxacin hydrochloride and a process for preparation thereof |
| 06/23/2005 | US20050137225 Aza-bridged bicyclic amine derivatives for use as novel cholinergic receptor ligands |
| 06/23/2005 | US20050137224 2-Cyanopyrrolidinecarboxamide compound |
| 06/23/2005 | US20050137223 Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease |
| 06/23/2005 | US20050137220 Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors |
| 06/23/2005 | US20050137216 Heterocyclic sodium/proton exchange inhibitors and method |
| 06/23/2005 | US20050137215 Antiarthritic and antiinflammatory agents; analgesics; the proline derivatives do not displace gabapentin from alpha-2-delta receptors |
| 06/23/2005 | US20050137214 Inhibitors of cyclin-dependent kinases 4 (cdk4); treating proliferative disorders such as cancer; salt of 6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one for example |
| 06/23/2005 | US20050137213 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis; antiproliferative, anticarcinogenic, antimetabolic agents; tubulin and topoisomerase II inhibitors; fungicides; synergistic administration with other anticarcinogenic agents |
| 06/23/2005 | US20050137202 Heterocyclic compounds as antiinflammatory agents and cyclooxygenase inhibitors |
| 06/23/2005 | US20050137201 Compositions useful as inhibitors of protein kinases |
| 06/23/2005 | US20050137199 Aza-quinolinol phosphonate integrase inhibitor compounds |
| 06/23/2005 | US20050137188 Heterocyclic compounds |
| 06/23/2005 | CA2549401A1 Heterocyclic anti-migraine agents |
| 06/23/2005 | CA2548487A1 Methods and compositions for slowing aging |
| 06/23/2005 | CA2548009A1 Naphthyridine derivatives and their use as modulators of muscarinic receptors |
| 06/22/2005 | EP1544199A1 Nitrogenous condensed-ring compound and use thereof as hiv integrase inhibitor |
| 06/22/2005 | EP1543006A1 Non-nucleoside reverse transcriptase inhibitors |
| 06/22/2005 | EP1543005A1 Imidazopyridine compunds as 5-ht4 receptor agonists |
| 06/22/2005 | EP1543004A1 N-substituted piperidinyl-imidazopyridine compounds as 5-ht4 receptor modulators |
| 06/22/2005 | EP1543003A2 Imidazo[1,2-a]pyridines |
| 06/22/2005 | EP1543002A1 Preparation of 1h-imidazo 4,5-c]quinolin-4-amines via1h-imidazo 4,5-c]quinolin-4-phthalimide intermediates |
| 06/22/2005 | EP1543001A1 Novel pyrazolopyridine derivatives as pharmaceutical agents |
| 06/22/2005 | EP1542999A1 1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity |
| 06/22/2005 | EP1542995A1 Novel isothiazole and isoxazole compounds as transforming growth factor (tgf) inhibitors |
| 06/22/2005 | EP1542994A1 Novel triazole and oxazole compounds as transforming growth factor (tgf) inhibitor |
| 06/22/2005 | EP1542990A1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors |
| 06/22/2005 | EP1542983A1 Heterodiamondoids |
| 06/22/2005 | EP1542734A1 Isotopically labelled indolinone derivatives and process for their preparation |
| 06/22/2005 | EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 06/22/2005 | EP1542688A2 1h-imidazo dimers |
| 06/22/2005 | EP1542685A1 Triazole derivatives as transforming growth factor (tgf) inhibitors |
| 06/22/2005 | EP1542684A2 Novel pyrazole compounds as transforming growth factor (tgf) inhibitors |
| 06/22/2005 | EP1317434A4 Preparation of risperidone |
| 06/22/2005 | EP1268466B1 Decahydro-isoquinolines |